Navigation Links
XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
Date:2/7/2008

VALLEY COTTAGE, N.Y., Feb. 7 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) announced today that Ron Bentsur, the Company's Chief Executive Officer, is scheduled to present at the 10th Annual BIO CEO & Investor Conference. Mr. Bentsur will present an overview of the Company including a discussion of Bicifadine, the Company's late-stage clinical compound for the treatment of diabetic neuropathic pain. Mr. Bentsur's presentation will take place on Wednesday, February 13, 2008 at 1:15 pm EST at the Waldorf Astoria Hotel in New York City.

A live webcast of the presentation will be available at: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=XTL&item_id=175250 2. An archived version of the webcast will be available following the conclusion of the live presentation.

ABOUT XTL BIOPHARMACEUTICALS LTD. XTL Biopharmaceuticals Ltd. ("XTL") is engaged in the development of therapeutics for the treatment of neuropathic pain and HCV. XTL is developing Bicifadine, a serotonin and norepinephrine reuptake inhibitor, for the treatment of diabetic neuropathic pain, which is currently in a Phase 2b study. XTL is also developing novel pre-clinical HCV small molecule inhibitors. XTL also has an active in-licensing and acquisition program designed to identify and acquire additional drug candidates. XTL is publicly traded on the NASDAQ and Tel-Aviv Stock Exchanges (Nasdaq: XTLB; TASE
'/>"/>

SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
2. Nabi Biopharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare Conference
3. China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results
4. Nabi Biopharmaceuticals Stockholders Approve Asset Sale
5. Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results
6. RiskMetrics Group (ISS) and Glass Lewis & Co. Support Nabi Biopharmaceuticals Proposed Asset Sale
7. XTL Biopharmaceuticals to Present at the Rodman & Renshaw 9th Annual Health Care Conference
8. XTL Biopharmaceuticals Ltd. Announces $9.6 Million Private Placement to Institutional Investors
9. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement and Release Date of Third Quarter 2007 Financial Results
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...re/ -- Reportlinker.com announces that a new marke..., Neurostimulation - A Global Market Perspecti...urostimulation---A-Global-Market-Perspective.html ...nthused by the growing base of aging population, a... as, Parkinson,s, and Alzheimer,s disease. Widespr...
(Date:12/2/2009)...swire-FirstCall/ -- Peregrine Pharmaceuticals, Inc...tient enrollment in a dose confirmation and dosime...d glioblastoma multiforme (GBM), the deadliest for...l antibody linked to a radioisotope being develope...ecifically targets cells at the center of brain tu...
(Date:12/2/2009)...cember 2 Gamida Cell announced tod...(animal study) safety and,efficacy of a gene thera...rnell Medical College and Gamida Cell. The product...h as Cooley,s Anemia. , Gamida Cell is de...vo,populations of stem/progenitor cells. The comp...
(Date:12/2/2009)...ire-Asia/ -- The world is going through,extraordin...is part of many,businesses and industries. It turn... immune to the economic downturn, because illness ...st of the difficult times this year, the pharmaceu...&D center in Shanghai, the largest of,its kind...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...pril 18 BioDuro & The National Center for,Safety ...ng announce their,receipt of full AAALAC accredita...preclinical toxicology and large animal DMPK for c...resident of Toxicology stated "Although,we have be...it is exciting,to receive this important, internat...
...hers have used the world,s thinnest material to cr...ck and ten atoms wide. , Reporting their peer-rev...Science, Dr Kostya Novoselov and Professor Andre G...e University of Manchester show that graphene can ...idual transistors having a size not much larger th...
... April 17 BrainCells Inc. (BCI), a,biopharmaceuti...dentify and,develop compounds that promote the gro...rvous system (CNS) diseases, announced today that ...n of its Series B financing, bringing,the total to...tes (NEA),along with current investors and Alexand...
Other Biology Technology:BioDuro & The National Center for Safety Evaluation of Drugs Received Full AAALAC Accreditation 2Graphene used to create world's smallest transistor 2BrainCells Inc. Expands Series B Financing to $50 Million 2
(Date:12/2/2009)...sts are reporting the first identification of subs...ion that changes harmless marine bacteria into kil...ears in ACS, Environmental Science & Technology ,...agues note that bleaching already has destroyed up...entists are searching for ways to slow or stop the...
(Date:12/2/2009)...one of your muscles can twitch, before the thought...ny floodgate of sortscalled an ion channelmust ope...et in the chemical signals that spur the cell to a...Standards and Technology (NIST) has allowed scient...mbrane for the first time, potentially offering in...
(Date:12/2/2009)...tist from the University of Salamanca and another ...of predators affects the behaviour of Acanthodact...ev Desert in the Near East. According to the study...nd different prey if they are under pressure from ...ed this result, but until now there had been very ...
Breaking Biology News(10 mins):Nervy research: Researchers take initial look at ion channels in a model system 2Lizards change their diet to avoid predators 2As Lawsuits Hit the MTA Personal Injury Lawyers Consider How Much is Too Much or Too Little 51154 1As Lawsuits Hit the MTA Personal Injury Lawyers Consider How Much is Too Much or Too Little 51154 2As Lawsuits Hit the MTA Personal Injury Lawyers Consider How Much is Too Much or Too Little 51154 3The next health tsunami 3A Noncommunicable diseases 51152 1The next health tsunami 3A Noncommunicable diseases 51152 2Is obesity an oral bacterial disease 3F 51150 1
...n why people are at greater risk of developing can... published today (June 2). , Scientists have disco... protect us from cancer may also determine how lon...y respected journal Science ?open up a new avenue .... , "We have discovered that proteins that preven...
...ect of a paycheck, good grade, or promotion wonder...now identified the brain circuitry responsible for...n the May 4, 2006, Neuron, Alison Adcock and colle... reveal how specific reward-related brain regions ... promote memory formation. , In their studies, th...
... causes of autism remain complex and mysterious, r...cate puzzle. In what they believe to be a signific... disorders" (ASD), researchers have developed a mo...ain hypertrophy characteristic of the disease. , I...da and his colleagues report the results of removi...
Other Biology News:Worm links cancer risk to ageing 2The brain's motivation station 2Mutant mice show key autism traits 2
...The Brownlee Precision Model 440 incorporates four...rcuitry in a friendly easy-to-use instrument. Each...er, an 8-pole Bessel lowpass filter, a highpass fi...ols. A control knob sets the amplifier parameters ...
...The NeuroLog System is a compact, versatile & modu...purposes including: Intracellular, Extracellular,... The NeuroLog Case & Power Supply unit (NL900...les are not only powered by this unit, but wiring ...
REK (R102-05) from European Collection of Cell Cultures (ECACC)
...The Brownlee Precision Model 410 is a four-channel...sed to amplify small signals from sources which ma...y noise. Each channel consists of a high gain/low ...ole lowpass filter, and an output offset control. ...
Biology Products: